No black box warning on record for Lunsumio

As of the latest FDA labeling reviewed, Lunsumio (MOSUNETUZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lunsumio medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Neurologic Toxicity, including Immune Effector Cell-Associated Neurotoxicity Syndrome : Can cause serious and life-threatening neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome (ICANS). Monitor patients for signs and symptoms of neurologic toxicity during treatment; withhold or permanently discontinue based on severity. ( 5.2 ) Infecti

No black box warning on record for Lunsumio

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Neurologic Toxicity, including Immune Effector Cell-Associated Neurotoxicity Syndrome : Can cause serious and life-threatening neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome (ICANS). Monitor patients for signs and symptoms of neurologic toxicity during treatment; withhold or permanently discontinue based on severity. ( 5.2 ) Infecti

Lunsumio Black Box Warning

No black box warning on record for Lunsumio

Other warnings & precautions

Lunsumio Black Box Warning

No black box warning on record for Lunsumio

Other warnings & precautions